NUDT1 and cancer: Although the possibility of killing cancer cells through targeting MTH1 is still controversial [30,31,32], a promising yet unexplored application of MTH1 inhibitors is to monitor disease progression that involves oxidative stress since elevated oxidative stress in cells occurs in a large number of chronic diseases including different types of cancers.